Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kimia Nafis is a prominent Iranian pharmaceutical and healthcare company focused on the distribution, marketing, and manufacturing of medicinal products and supplements. Established in 2003, the company operates as a strategic partner for several international brands, facilitating the availability of specialized treatments in the Iranian market. Their portfolio spans various therapeutic categories, including dermatology, gastroenterology, and general wellness, with a strong emphasis on high-quality supplements. Kimia Nafis maintains a manufacturing facility to support local production alongside its extensive distribution network. The company is recognized for its commitment to international quality standards and its role in bridging the gap between global pharmaceutical innovations and local patient needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kimia Nafis.